| abstract |
The present invention provides novel spiro[cyclobutane-1,3′-indolin]-2′-one derivatives of formula (I) n n n n n n n n n n in which Cy, R 1 , R 2 , R 4 , L, and m have the meaning given in the specification, and pharmaceutically acceptable salts thereof. The compounds of formula (I) are useful as bromodomain inhibitors in the treatment or prevention of diseases or disorders where bromodomain inhibition is desired. |